menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  • ReachMD Healthcare Image
    Medical News

    Study Suggests Unresolved Anxiety May Increase the Risk of Developing Dementia

  • ReachMD Healthcare Image
    Medical News

    COVID-19 Slowed Progress Toward Health-Related Sustainable Development Goals, I…

  • ReachMD Healthcare Image
    Medical News

    Mild COVID-19 Can Cause Long-Term Cognitive Losses, Finds Study

Programs

  • Transitioning to Trivalent Flu Vaccines: A Look at the Rationale and Counseling…
    VacciNation

    Transitioning to Trivalent Flu Vaccines: A Look at the Rationale and Counseling Strategies

  • Targeting Prevalent Flu Strains Through Strategic Vaccine Selection
    VacciNation

    Targeting Prevalent Flu Strains Through Strategic Vaccine Selection

  • TRANSFORM Trial: Overview and Potential Implications
    MinuteCE®

    TRANSFORM Trial: Overview and Potential Implications 

    0.75 program credits
  • Treating Breakthrough PONV: A Review of Therapeutic Approaches, Considerations,…
    Medical Industry Feature

    Treating Breakthrough PONV: A Review of Therapeutic Approaches, Considerations, and Guidelines

  • MACE and SGLT2 Inhibitors: Do They Have an Impact?
    MinuteCE®

    MACE and SGLT2 Inhibitors: Do They Have an Impact?

    0.75 program credits
  • Exploring Autophagy through Sigma-1 Receptor Activation: Innovative Therapeutic…
    CME/CE

    Exploring Autophagy through Sigma-1 Receptor Activation: Innovative Therapeutics for Alzheimer's Disease Beyond Amyloid Pathways

Clinical Practice

  • Cancer Care for All: Enhancing CRC Screening in Minority Populations
    Clinician's Roundtable

    Cancer Care for All: Enhancing CRC Screening in Minority Populations

  • Consensus Recommendations for Use of p16/Ki67 Dual Staining Cytology in the Man…
    CME/CE

    Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV

    0.25 credits
  • How to Talk to Patients about CRC Screening Options
    Clinician's Roundtable

    How to Talk to Patients about CRC Screening Options

  • Perioperative Immunotherapy for Resectable NSCLC: Evaluating Approved and Emerg…
    MinuteCE®

    Perioperative Immunotherapy for Resectable NSCLC: Evaluating Approved and Emerging Approaches

    0.50 program credits
  • Navigating therapeutic approaches in HCM: Unravelling recent evidence
    MinuteCE®

    Navigating therapeutic approaches in HCM: Unravelling recent evidence

    0.75 credits 4 episodes
  • How the HIF Pathway Orchestrates an Adaptive, Physiological Response to Anemia
    Medical Industry Feature

    How the HIF Pathway Orchestrates an Adaptive, Physiological Response to Anemia

Doctors Lounge

  • The Dynamic Practice: Exploring Locum Tenens Opportunities
    Spotlight on Locum Tenens

    The Dynamic Practice: Exploring Locum Tenens Opportunities

  • A Clinician's Guide to the ACIP Travel Vaccination Recommendations
    VacciNation

    A Clinician's Guide to the ACIP Travel Vaccination Recommendations

  • KOL Knockout™: Cancer Pain Management Edition
    CME/CE

    KOL Knockout™: Cancer Pain Management Edition

    1.50 credits
  • Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2-…
    CME/CE

    Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab 

    0.25 credits
  • Cultural and Aesthetic Considerations in Patients with Skin of Color
    Practical Dermatology

    Cultural and Aesthetic Considerations in Patients with Skin of Color

  • Recognizing and Addressing Medical Gaslighting in Healthcare
    NeuroFrontiers

    Recognizing and Addressing Medical Gaslighting in Healthcare

CME

  • TRANSFORMing Cardiovascular Care
    MinuteCE®

    TRANSFORMing Cardiovascular Care

    0.75 credits 5 episodes
  • Current Unmet Needs in the Field of Unresectable HCC
    MinuteCE®

    Current Unmet Needs in the Field of Unresectable HCC

    1.00 program credits
  • Pivotal Data Supporting First-Line Durvalumab/Tremelimumab in Unresectable HCC
    MinuteCE®

    Pivotal Data Supporting First-Line Durvalumab/Tremelimumab in Unresectable HCC

    1.00 program credits
  • IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
    CME/CE

    IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis

    0.25 credits
  • When Adjuvant Immunotherapy for Resectable NSCLC May Be the Better Approach
    MinuteCE®

    When Adjuvant Immunotherapy for Resectable NSCLC May Be the Better Approach

    0.50 program credits
  • Evolving Our View of the Coagulation Cascade and Stroke Management
    CME/CE

    Evolving Our View of the Coagulation Cascade and Stroke Management

    0.25 credits

Industry Feature

  • An Introduction to Squamous Cell Carcinoma of the Head and Neck
    Medical Industry Feature

    An Introduction to Squamous Cell Carcinoma of the Head and Neck

  • Thrombosis-Free Survival Data that May Inform the Way We Manage Patients with P…
    Medical Industry Feature

    Thrombosis-Free Survival Data that May Inform the Way We Manage Patients with Polycythemia Vera

  • EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups
    Medical Industry Feature

    EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups

  • Bridging the Disparity Gap in Multiple Myeloma Care: Navigating Challenges, Sei…
    Medical Industry Feature

    Bridging the Disparity Gap in Multiple Myeloma Care: Navigating Challenges, Seizing Opportunities

  • IgAN Insights: The Potential Role of the Complement System in Disease Progressi…
    Medical Industry Feature

    IgAN Insights: The Potential Role of the Complement System in Disease Progression

  • Patient-Centric Care for Managing Certain Manifestations of VHL Disease
    Medical Industry Feature

    Patient-Centric Care for Managing Certain Manifestations of VHL Disease

Schedule26 Jul 2024